We’re thrilled to announce that SyVento BioTech joined the prestigious Alliance for mRNA Medicines (AMM), marking our commitment to advancing mRNA technology and therapies. As a member of this global organization, we are at the forefront of groundbreaking research and innovation.

Thanks to this unique opportunity, we gain access to cutting-edge research, shared resources, and the collective expertise of the top minds in mRNA technology. We are excited to leverage the insights and connections gained through AMM to accelerate our projects and continue contributing to the future of mRNA therapeutics.

Thank you to AMM for welcoming us into this esteemed community. We look forward to achieving many more milestones together!